Moderna Cancer Vaccine: What You Need to Know

TKStories

Moderna and Merck have reported positive Phase 3 results for a personalized mRNA cancer vaccine targeting melanoma. The treatment could represent an important step toward personalized cancer care.  #CancerVaccine #Moderna #mRNA #Melanoma #MedicalNews  Moderna cancer vaccine, mRNA cancer treatment, melanoma vaccine, cancer breakthrough, personalized medicine, cancer research, medical technology, Keytruda

Transcript

00:00What if your cancer vaccine could be made just for you?

00:03Moderna and Merck have reported positive Phase 3 results

00:06for a personalized mRNA cancer vaccine targeting melanoma.

00:10The vaccine uses a patient's tumor data to train the immune system to attack cancer cells.

00:16Combined with Keytruda, it reduced the risk of cancer returning or spreading.

00:21But it's not a cure yet.

00:23Regulatory approval is still needed.

00:25Could personalized cancer vaccines be the future?

00:30Regulatory approval is still needed.

Category

Transcript

Comments

Recommended